医学
结直肠癌
转移
化疗
病态的
内科学
肿瘤科
淋巴瘤
治疗效果
坏死
放射科
癌症
胃肠病学
作者
Ping Wang,Yan Cui,Chenglin Li
出处
期刊:Chinese Journal of Hepatobiliary Surgery
[Chinese Medical Association]
日期:2009-12-28
卷期号:15 (12): 898-901
标识
DOI:10.3760/cma.j.issn.1007-8118.2009.12.006
摘要
Objective To assess the therapeutic efficacy of comprehensive management and pre-operative chemotherapy of liver metastasis of colorectal cancer. Methods Two weeks before and after the neoadjuvant chemotheray. Its therapeutic efficacy was assessed by: 1) BUS or CT,2)TACE,3) BUS after TACE,4)Resection,5)6 courses of SVC,6)BUS or CT. Results BUS displayed that PSV was 0. 87m/s and RI 0. 83 in internal artery of tumor. After TACE for 1 week, PSV was 0. 63m/s and RI 0. 85 (P<0. 05). Pathological examination showed that the regional necrosis and lymphoma repose were significantly different. All the patients undergoing the TACE were alive without tumors and the 1-year survival rate was 92. 9%. Conclusion The neoadjuvant chemotherapy by TACE can decrease blood supply and increases necrosis for tumors.
Key words:
Colorectal-neoplasms; Liver-metastasis; TACE; Neoadjuvant chemotherapy
科研通智能强力驱动
Strongly Powered by AbleSci AI